Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL595527 | 0.81 | ALDH1A1 (0.34) | ALDH1A1L3MBTL1 | |
| SCHEMBL27413913 | 0.79 | KDM4E (0.35) | FFAR1 | |
| SCHEMBL2018150 | 0.75 | RECQL (0.35) | FFAR1 | |
| SCHEMBL2013407 | 0.75 | FFAR1 (0.32) | FFAR1 | |
| SCHEMBL27621059 | 0.75 | FFAR1 (0.32) | FFAR1 | |
| SCHEMBL4263566 | 0.75 | HRH1 (0.45) | FFAR1 | |
| SCHEMBL24258919 | 0.74 | KCNH2 (0.32) | FFAR1 | |
| SCHEMBL22800177 | 0.73 | KDM4E (0.34) | ALDH1A1L3MBTL1 | |
| SCHEMBL16178953 | 0.72 | KCNH2 (0.46) | — | |
| SCHEMBL22800874 | 0.71 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210230143-A1 | CYCLOHEXYL ACID TRIAZOLE AZINES AS LPA ANTAGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210230143-A1 | CYCLOHEXYL ACID TRIAZOLE AZINES AS LPA ANTAGONISTS | LPAR3, LPAR1, LPAR2 | ALDH1A1 2244/4885L3MBTL1 4166/4885FFAR1 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.